(S)-1-[N2-(1-Carboxy-3-phenyl-d5-propyl)-L-lysyl]-L-proline; Acerbon-d5; Alapril-d5; Amicor-d5; Carace-d5; Cipral-d5; Cipril-d5; Coric-d5; Diroton-d5; Inopril-d5; Irumed-d5; Laaven-d5; Linopril-d5; Linvas-d5; Lipril-d5; Lisipril-d5; Lisitec-d5; Lisopril-d5; Lisoril-d5; Lispril-d5; Listril-d5; Lizinopril-d5; Lizonoton-d5; Longes-d5; Loril-d5; N-(1(S)-Carboxy-3-phenyl-d5-propyl)-L-lysyl-L-proline; N2-[(S)-1-Carboxy-3-phenyl-d5-propyl]-L-lysyl-L-proline; Nanopril-d5; Noperten-d5; Novatec-d5; Optimon-d5; Presiten-d5; Prinil-d5; Prinivil-d5; Prinvil-d5; Skopryl-d5; Tensopril-d5; Tensyn-d5; Vitopril-d5; Vivatec-d5; Zestril-d5;(S)-Lisinopril-d5
Lisinopril-d5 Sodium is a fully characterized chemical compound used as a reference standard of API Lisinopril. The standard offered is compliant with regulatory guidelines. Lisinopril-d5 Sodium is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1356847-28-3
Related products
N-(1-Carboxy-3-phenylpropyl)-S-lisinopril Trisodium Salt (Mixture of diastereomers)
M.F.
M.W. 633.67
CAT# AR-L06104
CAS# NA
Lisinopril Impurity H (Dimer Impurity, Mixture of Diastereomers)
M.F.
M.W. 695.86
CAT# AR-L01752
CAS# NA
